APVV-17-0054 - "New Oral Anticoagulants in the Prevention of Major Cardiovascular Diseases, their Effect on Thrombocytes, Drug Interactions, Safety and Possibilities of the Therapy in Oncology Patients", co-author: Juraj Sokol, MD, PhD
Grant CU/56/2018 - ''Laboratory and Molecular Genetic Diagnostics of Patients with von Willebrand's Disease in the Northern Slovakia", Jana Zolkova, MA
Grant CU/64/2018 ''Laboratory and Molecular Diagnostics of Congenital Disorders of Fibrinogen", Tomas Simurda, MD
Grant APVV-16-0020 - "Specific laboratory monitoring of platelet reactivity in patients with acute myocardial infarction treated with new P2Y12 receptor antagonists", prof. Jan Stasko, MD, PhD.
Grant VEGA 1/0187/17 - "Genetic Background and Hemostatic Changes in the Patients with von Willebrand Disease", Juraj Sokol, MD, PhD.
Grant VEGA 1/0168/16 - "Monitoring of hemostasis and detection of microRNAs in the prediction of pregnancy complications in women with risk pregnancies", prof. Jan Stasko, MD, PhD.
Grant CU/98/2017 - Lubica Vadelova, MA
Grant CU/102/2017 - Tomas Simurda, MD
Grant CU/502/2014 - Lucia Stanciakova, MD, PhD
Grant CU/314/2015 - Marian Fedor, MD, PhD
Grant CU/271/2015 - "Genetic background of thrombocytopenic thrombophilia in patients with fetal loss", Juraj Sokol, MD, PhD.
Grant CU/334/2015 - Tomas Simurda, MD
Grant CU/216/2016 - Zuzana Mazancova, MD
Grant CU/153/2016 - Lucia Stanciakova, MD, PhD
Grant CU/176/2016 - Radoslava Simonova, MD
Grant VEGA 1/0016/12 - “The use of cellular and molecular markers in the assessment of the therapeutic angiogenesis in patients with critical limb ischemia“, prof. Staško – 2012-2014.
Grant APVV-0222-11 - “Possibilities of the stent restenosis and thrombosis prediction in patients with acute cononary syndrome undergoing percutaneous coronary intervention“, prof. Kubisz – 2012-2015.
Grant CU/475/2013 - “The clinical significance of quantification JAK2V617V mutations in patients with Ph negative myeloproliferative disease", Zuzana Jedinakova, MD - 2013.
Grant CU/440/2013 - “The use of cellular and molecular markers in the assessment of the therapeutic angiogenesis in patients with critical limb ischemia", Marian Fedor, MD - 2013.
Grant CU/381/2012 - “Abnormalities of platelet aggregation: genetic variability of glycopropein 6 gene", Juraj Sokol, MD - 2012.
Grant CU/319/2012 - “Monitoring of changes in hemostasis in healthy pregnant women with tromboelastomerie (ROTEM ®) and its contribution to a better prediction of hemostasis disorders ", Lukas Duraj, MA - 2012.
Grant VEGA 1/0029/11 - “Platelet glycoprotein receptors polymorphisms in the sticky platelet syndrom“, prof. Kubisz - 2011-2013.
Grant CU/285/2011 - “The study gene polymorphisms in relationship to the absence of response to the antiplatelet therapy in sticky platelet syndrom“, Kotuličová MD. – 2011.
Grant VEGA 1/0018/10 - “The diagnostics of hereditary thrombophilia as a possible cause of increased risk of arterial thrombosis in the Slovak population“, assoc. prof. Staško – 2010-2011.
Grant CU/45/2009 – “Vascular endothelial growth factor (VEGF) in the etiopathogenesis of endothelial dysfunction in the patients with type 2 diabetes mellitus with normo- and/or microalbuminuria“, Chudý, MD., PhD. – 2009.
Grant CU/57/2009 – “Sticky platelet syndrom - the use of Gas6 (Gas6 c.834+7G>A) gene variability in the research of its etiopathogenesis“, Bartošová, MD., PhD., 2009.
Grant CU/59/2009 – “Risk factors of serious hemostasis disturbances in the patients with polycythemia vera (PV) a essential thrombocythemia (ET)“, Jedináková MD, 2009.
Grant VEGA 1/0067/08 - “Importance of Sticky platelet syndrome for the prevention and treatment of cardiovascular diseases“, prof. Kubisz - 2008-2010.
Grant CU/421/2008 – “Vascular endothelial growth factor (VEGF) in the etiopathogenesis of endothelial dysfunction in the patients with type 2 diabetes mellitus with normo- and/or microalbuminuria“, Chudý, MD., PhD. 2008.
Grant CU/425/2008 – “Sticky platelet syndrom - the use of Gas6 (Gas6 c.834+7G>A) gene variability in the research of its etiopathogenesis“, Bartošová, MD., PhD., 2008.
Grant CU/424/2008 – “Risk factors of serious hemostasis disturbances in the patients with polycythemia vera (PV) a essential thrombocythemia (ET)“, Jedináková MD, 2008.
Grant MH SR 2006/36-MFN-03 - “Therapeutic angiogensis of the critical limb ischemia using authologous stem cells transplantation“, prof. Kubisz, 2006-2009, successfully finished in 2009.
Grant VEGA 1/3381/06 - “Diagnostics and screening of the most frequent thrombophilic states in the Slovak population”, Assoc. prof. Staško, 2006-2008.
Grant VEGA 1/2309/05 - “The utility of the endothelial dysfunction parameters as predictive markers of the cardiovascular complications risk in patients with diabetic nephropathy”, prof. Kubisz, 2005-2007.
Grant KEGA 3/1131/03: “Textbook of hematology and blood transfusion”, prof. Kubisz, 2003-2005, successfully finished in 01/2006.
Grant JFMED CU 1/2003 - “Prothrombin 20210A gene mutation in healthy Slovak population and in the patients with thrombophilic state”, prof. Kubisz, 2003-2005.
Grant MUH 5/2003 - ”The occurrence of factor V Leiden in the material of the National Center of Hemostasis and Thrombosis in Martin”, prof. Kubisz, 2003-2005.
Grant MUH 6/2003 - “The use of flow-cytometry for the assessment of integrins on the blood cells, 2003-2005.
Grant MUH 7/2003 - ”Oral contraceptives and thrombophilic states” 2003-2005.
Grant MUH 8/2003 - “Flow-cytometry in the diagnostics of gastrointestinal MALT-lymphomas”, prof. Kubisz, 2003-2005.
Grant MUH 9/2003 - “Endothelial and platelet markers in the essential hypertension”, prof. Kubisz, 2003-2005.